The avolition/apathy domain of negative symptoms includes motivation-and pleasure-related impairments. In people with schizophrenia, structural and functional abnormalities were reported in key regions within the motivational reward system, including ventral-tegmental area (VTA), striatum (especially at the level of the nucleus accumbens, NAcc), orbitofrontal cortex (OFC), as well as amygdala (Amy) and insular cortex (IC). However, the association of the reported abnormalities with avolitonapathy is still controversial. In the present study, we investigated white matter connectivity patterns within these regions, using a probabilistic analysis of diffusion tensor imaging (DTI) data, in male subjects with schizophrenia. Thirty-five male subjects with schizophrenia (SCZ) and 17 male healthy controls (HC) matched for age, underwent DTI. SCZ were evaluated using the Schedule for Deficit Syndrome (SDS), the Positive and Negative Syndrome Scale (PANSS), and the MATRICS Consensus Cognitive Battery (MCCB). Probabilistic tractography was applied to investigate pathways connecting the Amy and the NAcc with the OFC and IC. Reduced fractional anisotropy (FA) was observed in left Amy-ventral anterior IC connections, in SCZ compared with controls. This abnormality was negatively correlated with avolition/apathy but not with expressive deficit scores. SCZ showed also a reduced connectivity index between right NAcc and medial OFC, as compared with controls. Finally, the left NAcc-dorsal anterior IC connectivity index was negatively correlated with working memory scores. Our results indicate that only the avolition/apathy domain of negative symptoms is related to abnormal connectivity in the motivation-related circuits. The findings also demonstrate that distinct alterations underlie cognitive impairment and avolition/apathy.
Introduction
Schizophrenia is a heterogeneous complex disorder, presenting with several distinct psychopathological features, as well as alterations of cognitive and real-life functioning. Although negative symptoms have long been recognized as a core features of the disease, they remain so far an unmet therapeutic need. [1] [2] [3] [4] Negative symptoms are present since the early stage of the disorder and have shown an elevated stability along the course of the illness, mostly in the presence of poor premorbid outcome and male gender. 5, 6 Primary negative symptoms represent the phenomenological expression of the disorder, while secondary negative symptoms may be caused by comorbid conditions (eg, depression), as well as by treatment-related or environmental factors. [7] [8] [9] [10] Both primary and secondary negative symptoms cluster in 2 domains: a motivational one, consisting of avolition, anhedonia, and asociality, and an expressive deficit domain, consisting of blunted affect and alogia. [11] [12] [13] The 2 domains, avolition/apathy and expressive deficit, are likely subtended by distinct neurobiological alterations. 14, 15 Only the avolition/apathy domain is thought to be associated with different aspects of motivational impairment. [14] [15] [16] [17] Several studies indicated gender difference in the expression and severity of negative symptoms, along with those reported for other clinical, social, and cognitive variables, since the prodromal phase. 18 In studies on people at high risk of psychosis, men showed more severe negative symptoms, worse social functioning, and longer duration of untreated illness. 19 Although discrepant results were published, [20] [21] [22] [23] the majority of findings demonstrated higher scores of disorganization and negative symptoms in male people with schizophrenia, with some authors suggesting that men present more severe negative symptoms while women more severe affective symptoms. 6, [24] [25] [26] Furthermore, male gender was found highly prevalent in the deficit form of schizophrenia and in association with persistent negative symptoms. 9, 10, 27, 28 The pathophysiology of avolition/apathy is still unknown; however, the most updated hypotheses indicate an involvement of the motivation-reward system, corresponding to the National Institute of Mental health (NIMH) Research Domain Criteria (RDoC) positive valence system. 14, 15 Although several brain regions are part of this circuit, the nucleus accumbens (NAcc) and the ventral tegmental area (VTA) dopamine pathways appear to be central nodes. 29, 30 The ventral striatum (VS), which includes NAcc and most ventral and medial part of caudate and putamen, is involved in reward prediction error. The VS receives its main cortical input from the orbital frontal cortex (OFC) and anterior cingulate cortex (ACC) and a massive dopaminergic input from the VTA. The prefrontal nodes of the circuit include the caudal, sensory region, of both the OFC and insula cortex (IC); the rostral OFC, the ventromedial cortex (vmPFC), and the dorsal ACC (dACC). The VS projects to the ventral pallidum and to the VTA, which, in turn, project back to the prefrontal cortex, thus completing a cortico-striato-pallidalthalamocortical loop. In addition, other structures including the amygdala (Amy) and hippocampus, are key components of the reward system. 31, 32 Together these structures form the essential nodes of the circuit that serves to optimize the behavioral response to innate and learned rewards, and to regulate goaldirected behavior.
Disturbed communication ("disconnectivity") within and between cortical and subcortical areas may contribute to compromise macrostructural circuits that subserve key cognitive capacities and goal-directed behavior. 33, 34 Postmortem and genetic studies have provided evidence for anatomical disconnectivity and myelination abnormalities in schizophrenia 35 , 36 . White matter (WM) alterations are widely recognized as the basis for this kind of disconnectivity, [37] [38] [39] and many findings underscore WM abnormalities since the early stages of schizophrenia. [40] [41] [42] Previous functional connectivity studies have found alterations in multiple cortical and subcortical regions. [43] [44] [45] [46] [47] [48] [49] Numerous studies have attempted to identify the neural substrates of motivational deficits in schizophrenia, but these studies have not produced consistent findings as to the specific nodes or connections involved. 14, 50 Diffusion tensor imaging (DTI) allows to study the WM microstructure and integrity. 51 DTI has been used to examine WM properties, and is sensitive to WM fiber coherence, density, and myelination. Fractional anisotropy (FA) is a quantitative measure of directionally averaged diffusion of water molecules in vivo, so that areas of sparse, poorly myelinated, or divergent fibers have low FA values. 52 There are various approaches to analyzing DTI data, including region of interest (ROI), voxel-based and tractoriented methods. Studies applying these types of analysis have provided evidence for frontotemporal abnormalities in subjects with first episode psychosis (FEP) and fronto-temporo-limbic impairments in people with schizophrenia. 37, 41, 42, [53] [54] [55] Furthermore, lower FA values in the right superior longitudinal fasciculus (SLF), right inferior longitudinal fasciculus (ILF), right arcuate fasciculus (AF), left uncinate fasciculus (UF), right cingulum bundle, inferior fronto-occipital fasciculus and right fornix (FX), were found to correlate with negative symptom severity. 41, [56] [57] [58] [59] [60] Although there has been a large support for the disconnectivity model of psychosis, the relationships between WM microstructure and negative symptom domains remain largely unexplored. Findings concerning reduced FA along WM pathways in the reward system are still sparse and abnormalities in the anterior limb of the internal capsule, the anterior thalamic radiation, the FX or the UF were reported. [61] [62] [63] [64] Very few DTI studies have reported an association of WM alterations with specific negative symptoms. These findings include an association of abnormal connectivity between medial OFC (mOFC) and right ACC with more severe anhedonia-asociality and avolition-apathy scores of the Scale for Assessment of Negative Symptoms (SANS), and a negative correlation between reduced FA values of the anterior corpus callosum (CC) and avolition-apathy scores of the SANS. 39, 65 In the present study, using a bilateral probabilistic approach, we aimed to specifically investigate the WM connections between major brain regions of the reward system and to evaluate their associations with negative symptoms domains. We selected a sample of male patients, due to the strong association, supported by the literature, between negative symptoms and male gender. NAcc, VTA, Amy, dorsal-lateral PFC (dlPFC), mOFC, lateral OFC (lOFC), dorsal-anterior IC (daIC), ventral-anterior IC (vaIC) and posterior IC (pIC) have been identified as ROIs in cortical and subcortical areas. We hypothesized that (a) subjects with schizophrenia (SCZ) would have reduced connectivity strength between these ROIs, and/or reduced integrity of the corresponding fibers, as compared with healthy controls (HC); (b) the eventual alterations in WM tracts would be correlated with the severity of avolition/apathy but not with expressive deficit; and (c) the eventual associations between abnormal structural connectivity and cognitive impairment would occur in different pathways.
Materials and Methods

Subjects
Thirty-five patients with chronic schizophrenia were recruited from the outpatient unit of the Department of Psychiatry of the University of Naples SUN between September 2010 and July 2012. All subjects were right-handed and male. Inclusion criteria were: a DSM-IV diagnosis of schizophrenia confirmed by the Mini International Neuropsychiatric Interview-Plus (MINIPlus); age between 18 and 65 years; a negative history of mental retardation, head trauma with loss of consciousness, drug abuse, or dependence in the preceding 6 months (except for smoking); clinically stable (ie, no hospitalization or change in psychotropic medication for 3 months prior to scanning) to avoid the presence of severe positive symptoms that might cause secondary negative symptoms; treatment with second generation antipsychotics (SGA).
Seventeen right-handed healthy control (HC) were recruited from the community via flyers, they were all male and matched for age (±3 years) with schizophrenia patients. Exclusion criteria were: past or current mental illness using the MINI-Plus Interview; family history of mental illness or psychiatric hospitalization; history of head injury with a loss of consciousness, substance abuse or dependence (except for smoking) and the use of drugs that might affect central nervous system functions.
The study was approved by the University Ethics Committee. After a complete description of the study, a written informed consent was obtained from all participants.
A subsample of 18 SCZ and 10 HC, who completed a taskrelated functional magnetic resonance imaging (fMRI) study, was included in a previous publication. 113 
Clinical and Neuropsychological Assessments
All subjects were interviewed to evaluate sociodemographic variables, including age, education, and socioeconomic status.
Patients were administered the Schedule for the Deficit Syndrome, 66 a semistructured interview through which avolition/apathy was assessed by summing the scores on the items Curbing of Interests, Diminished Sense of Purpose, and Diminished Social Drive, with higher scores indicating greater avolition/apathy. Expressive deficit was assessed by summing the scores on the items Restricted affect, Diminished emotional range, Poverty of speech. [66] [67] [68] Patients were also administered the Positive and Negative Syndrome Scale (PANSS) 69 to assess positive symptoms, depression and disorganization dimensions; and the MATRICS Consensus Cognitive Battery (MCCB) to assess the presence of cognitive impairments within the following cognitive domains: Speed of Processing, Attention/Vigilance, Working Memory, Reasoning and Problem Solving, and Social Cognition. 70, 71 The daily antipsychotic dose on the day of scanning was converted to chlorpromazine equivalents following Gardner et al. 72 
MRI Acquisition Parameters
All MRI studies were carried out at 3 T on the same MRI scanner (Achieva, Philips Medical Systems, Best, The Netherlands). DTI data were acquired using an EPI sequence (repetition time/ echo time [TR/TE] 9300/102 ms, voxel 2 × 2 × 2 mm 3 , 32 directions uniformly distributed in 3-dimensional (3D) space 25, B-factors 0, and 1000 s/mm 2 , 50 axial slices covering the whole brain). In addition, a 3D T1-weighted brain volume (Turbo-Field-Echo sequence, TR/TE 7.7/3.5 ms, voxel 1 × 1 × 1 mm 3 , 181 sagittal slices covering the whole brain) was acquired to improve spatial normalization of the studies to the MNI space (see below). During the MRI study, the subjects were laying supine with the head lightly fixed by straps and foam pads to minimize head movement.
Regions of Interest
For tractographic analysis, a set of ROIs relevant to the reward system was chosen, following the approach proposed by Bracht et al, 73 integrated by a set of insular ROIs. The following ROIs were thus defined bilaterally as seeds: NAcc (5-mm radius sphere, MNI coordinates of the center ±8, 11, −9), 74 Amy (as defined in the WFUPick-Atlas 75 ), VTA (4-mm radius sphere, MNI coordinates of the center ±5, −20, −10). 76 As target ROIs, lateral and medial Orbito-Frontal Cortex (OFC), dorsal-lateral PreFrontal Cortex (DLPFC), along with ventral-anterior (vaIC), dorsal-anterior (daIC), and posterior (pIC) insular cortex ROIs were defined as follows: 80 
Probabilistic Tractography
DTI preprocessing and probabilistic tractography were carried out using the software modules provided in the FMRIB Software Library (FSL, http://fsl.fmrib.ox.ac.uk/fsl). All DTI datasets were preliminarily corrected for head movements and eddy currents distortions using eddy_correct, 81 correcting accordingly diffusion sensitizing gradient directions. 82 A brain mask was obtained from the B0 images using the Brain Extraction Tool routine, 83 and a diffusion-tensor model was fitted at each voxel using FSL's algorithm for Bayesian Estimation of Diffusion Parameters Obtained using Sampling Techniques (BEDPOSTX). From the affine co-registration parameters (translation along and rotation around the 3 axes) the mean movement over the brain mask was calculated for each of the 32 DTI volumes, as compared with the previous one. To avoid the effects of motion, which strongly influences apparent diffusion parameters, studies exceeding at any time point 3 mm of head movement were excluded from the analysis, and mean head movement was used as covariate in the second-level analysis (see below).
Deskulled B0 volumes were then normalized to the MNI space using the corresponding T1-weighted volumes as a proxy, using the 152 subject T1 template provided by SPM, and the FMRIB's Linear Image Registration Tool, 84 and the resulting normalization matrices were inverted and applied to the ROIs (defined in the MNI space), to apply them onto each patient's study. Quality of the normalization was assessed visually by verifying the match between normalized B0 volumes and the EPI template provided with SPM.
Probabilistic tractography was then carried out using ProbTrackx, 85 modeling 5000 iterations within each voxel of the seed ROI, with a curvature threshold (cosine of the minimum allowable angle between 2 steps) of 0.2, a step length of 0.5, and a maximum number of 2000 steps. For each seed-target couple, the percentage of the total pathways starting from the seed that reaches the target, was used as measure of the connectivity strength between the 2 ROIs (Connectivity Index, CI). In addition, the cumulated FA over each pathway was calculated, providing a measure of its structural integrity. For both CI and FA calculations, no threshold was used given the lack of consensus on this statistical issue. 86 For each seed, only connections to homolateral target ROIs were probed.
Statistical Analysis
Statistical analysis was carried out by linear regression analysis using SPSS (version 15.0, SPSS Inc, Chicago, IL). General linear model was fitted separately for each measure to assess differences between groups and correlations with clinical scores, including in the model age and mean head movement (root mean square realignment estimates, RMS), as derived from the eddy_correct procedure. Results were considered significant for P < .05, corrected according to Bonferroni for the number of connections assessed. In particular, as only homolateral connections were probed, a total of 36 seed-target couples were tested (3 seeds × 6 targets × 2 hemispheres), so that P < .0014 was used as statistical threshold.
Results
Subject Characteristics
The MRIs from 5 patients were discarded due to excessive movement artifacts at visual inspection, so that only 30 patients were included in the group-level analysis. The remaining 30 patients were not significantly different in terms of age from the HC group (F = 3.912; df = 1, 46; P = .054). In addition, age and RMS were entered as nuisance covariates in the analysis, as patients moved significantly more than HC during the scan (RMS 0.418 ± 0.119 vs 0.346 ± 0.099 mm, P = .041), and there was a trend for older age in SCZ (37.0 ± 7.9 vs 32.2 ± 8.3 years, P = .054). A significant group difference was observed in paternal education (F = 8.083; df = 1, 46; P = .007), maternal education (F = 4.228; df = 1, 46; P = .046), and educational level (F = 9.388; df = 1, 38; P = .004), between all patients and HC.
Patients had significantly lower working memory than controls (F = 31.486; df = 1, 36; P < .001) and all other evaluated MCCB scores showed significant differences between groups, with patients obtaining lower scores than controls (for all pairwise comparisons, P < .001). Table 1 summarizes demographic, psychometric and clinical characteristics of the sample.
Group Comparison on the Connectivity Strength and FA Between Couples of ROIs
In 2 out of the 18 pathways, SCZ had significantly lower CI or FA values than controls. SCZ showed a significantly lower CI between right NAcc (rNAcc) and homolateral mOFC compared with HC (Beta In = 0.524, t = 4.474, P = .0001) (Figure 1) . No other main effect of group was found on the connectivity strength in any of the assessed paths. FA of the pathways between left Amy (lAmy) and vaIC was significantly decreased in SCZ compared with HC (Beta In = 0.390, t = 2.974, P = .0048) (Figures 2 and 3) . No other group difference in group comparisons was found for the FA calculated for each remaining pathway.
Relationship Between Connectivity Data and Clinical Variables in SCZ
As shown in Figure 4 , a significant negative correlation was found in SCZ between FA in pathways connecting lAmy to vaIC and avolition/apathy scores (Beta In = −0.593, t = −3.694, P = .0013). Expressive deficit did not correlate with connectivity values of any of the 18 pathways. CI of the pathways between left NAcc (lNAcc) and daIC correlated negatively with working memory scores (Beta In = −0.600, t = −3.694, P = .0013) ( Figure 5 ). No correlation was found between Speed of Processing, Attention/Vigilance, Reasoning and Problem Solving, and Social Cognition MCCB scores, or PANSS positive, disorganization and depression scores, and any of the connectivity values obtained.
Discussion
In this study, we performed a probabilistic DTI analysis to investigate structural connectivity alterations in WM pathways connecting key regions of the reward system and their associations with negative symptom domains in SCZ.
Our results indicated FA abnormalities in lAMY-vaIC connections in patients compared to HC and that these abnormalities were negatively correlated with the avolition/apathy but not with the expressive deficit domain of negative symptoms. Since the pathways connecting lAMY-vaIC are involved in updating and retrieving the value information to support motivated behavior, 87, 88 the correlation observed with the severity of avolition/apathy domain corroborate the hypothesis that motivation dysfunctions derives from a difficulty in using reward-related information to guide goaldirected behavior. Furthermore, in SCZ we found a reduction of connectivity strength between rNAcc and mOFC, that is, a disruption in frontostriatal circuits responsible for value representation, which is essential for reinforcement learning. [89] [90] [91] [92] These data are in line with the hypothesis that people with SCZ have difficulties in representing or utilizing expected values to adaptively motivate goal-directed behavior. [93] [94] [95] Until now, limited literature data documented a relationship between impaired WM FA in frontal and temporal regions and negative symptom severity, but very few studies have investigated the relations of specific WM alterations with defined negative symptom domains. 39, 49, 56, 57, 59, 65 Furthermore, these studies have assessed negative symptoms with firstgeneration instruments, such as SANS, in which the assessment of avolition/apathy is carried out only at the behavioral level, that is, without a clear assessment of inner experience dysfunction and lack of interest or motivation, and includes items which do not belong to the negative symptom constructs. The severity of avolition/apathy as assessed with these instruments might be related to factors other than motivation, for example, cognitive dysfunction or depression. Our study used the only first-generation instrument that did not present this limitation, the SDS, which specifically investigate the lack of motivation or interest as the cause of the symptoms included in the avolition/apathy domain.
Our main findings support the hypothesis of an altered communication within brain regions involved in transferring the information from a limbic-striatal circuit, coding for experienced value and cue-guided choice, to a corticostriatal circuit implicated in goal-directed choice. The NAcc and the VTA dopamine neurons appear to be at the heart of the circuit involved in the neurophysiology of reward-guided behavior. 31, 96 The striatum is also thought to be a fundamental interface that integrates value representation and reward prediction with action-value signals and action contingency learning in order to choose the action with the highest expected utility. The literature suggests a differentiation of striatum regions and connected cortical and subcortical nodes, with functions more reward-related in the ventral-medial regions, whereas more associative and motor-related in dorsallateral section. 31, 32, [96] [97] [98] In particular, the Amy, a prominent limbic node connected with the medial regions, provides contextual information used for adjusting motivational levels. It has an important role in reward processing, that seems to be critical for stimulus-reward associations. [99] [100] [101] [102] [103] Specifically, the basolateral amygdala (BLA) supports orienting of attention to salient cues, uncertainty about outcome probability or intensity of stimuli, 104 and its activity is modulated by the predictability of both appetitive and aversive events. The insula, another important node projecting to the medial striatal regions, is responsible for evaluating the motivational salience of events and acts as an interface between external information and internal motivational states. 105 One of the leading roles is to take part, with the dACC, in the salience network, a paralimbic emotional salience processing distributed circuit, that is activated in response to pain, unexpected outcomes (due to errors in the expectation formation) and other threats to homeostasis. [106] [107] [108] [109] Error awareness activates predominantly the vaIC, whereas salience processing seems to activate to a greater extent the daIC and the posterior insular regions. VaIC activations to unexpected/aversive stimuli may reflect affective response to such stimuli, while the daIC is involved in integrating this affective response to attentional or executive mechanisms by recruiting the autonomic nervous system (arousal) and working memory system. 110 Recent studies in animals have clarified the interaction between IC and BLA in instrumental learning and memory. 87 The BLA is involved in encoding and updating changes in outcome value; the connections between AMY and anterior IC and those between the latter and NAcc core, play a critical role in retrieval of the encoded changes in outcome values to guide choice between goal-directed actions. 88, 111 In fact, the limbic regions of the striatum, such as the NAcc core, transfer the information from the IC to the "associative" dorsal-medial striatum and the "sensorimotor" dorsolateral striatum, connected to the cortical executive nodes, to influence goal-directed behavior. Our finding of a reduced FA from lAMY to vaIC indicate that in these patients the connections subserving the activation of motivated behavior are impaired. Our data seem to confirm that impaired functioning of the reward system and altered interactions with the salience circuit are more associated with the experiential, motivation-related domain of negative symptoms. In line with this perspective, Morris et al 112 found, in subjects with SCZ, an association of high avolition scores with bilateral Amy activation deficits, associated with impaired encoding of predicted values, and a deficient activity in the dorsal caudate, during valued actions. These findings, together with our previous fMRI data in these subjects 113 indicating an association between a reduced activation of the dorsal caudate and avolition/apathy scores, converge in indicating that motivational impairment in people with schizophrenia may result from a deficit in integrating experienced outcome value with action selection to guide behavior. [112] [113] [114] [115] In our present study, we also observed a reduced structural connectivity between rNAcc and mOFC in male people with schizophrenia in line with a deficit in representing the potential reward outcome. 104, 116, 117 In fact, the circuit including NAcc and OFC is critical for encoding prediction about future outcome (expected value) for reward-guided decision making. 96, 114, 115, [118] [119] [120] [121] [122] Two previous studies found WM abnormalities within rNAcc and mOFC pathways, already in the early stage of the disease, and reported correlations with more severe psychopathology (including anhedonia/asociality, avolition/apathy, blunted affect, and hallucinations). 39, 40 The association of the WM abnormalities in this circuit with both negative and positive symptoms might indicate a relationship to psychosis in general. In our chronic stabilized patients, there was no association between the abnormal connectivity in this circuit and positive or negative symptoms, suggesting that these abnormalities might be worsened by acute psychotic state. As a matter of fact, alterations within the ventral striatum were found during the acute phase in first-episode drug-naive subjects with schizophrenia [123] [124] [125] and in subjects at risk for psychosis who later converted, but not in chronic, stabilized patients treated with second-generation antipsychotics. 113, 126, 127 Additionally, in our study working memory scores showed a negative correlation with the connectivity strength from the lNAcc to the daIC, which points to dysfunctions of the motivational salience as a substrate for cognitive impairments, but not for negative symptoms, in schizophrenia. As discussed above, the daIC is involved in the salience processing and in cognitive and autonomic activation, with a general recruitment of attention, executive functions, and working memory resources (achieved by the activation of several other brain areas, such as anterior cingulate, supplementary motor area, thalamus, brainstem, and parietal lobule). 110 In accordance with our findings, available evidences suggest that negative symptoms and cognitive deficits are 2 independent domains. 3, [128] [129] [130] [131] [132] [133] The relationship between cognitive impairments and negative symptoms is still unclear. Although a common or overlapping pathophysiology has been hypothesized, the extent of such overlap has not been investigated. 8, 133 Several studies have reported weak relationships between cognitive functions and negative symptoms, but overall evidence confirmed that the 2 domains are independent, 3, 28, 132, 133 as suggested by our data. Our findings have to be interpreted in light of some limitations. First, all subjects were males, which limit the generalizability of our results. Second, the sample size is relatively small, which further limit the possibility of generalizing the results. Third, the small number of HC included in the analysis could prevent the detection of more significant results. A replication of our findings in a larger sample, including both sexes and a higher number of HC is required in future studies. Furthermore, we did not use a statistical threshold for both CI and FA calculations, that can lead to spurious results in DTI analyses. Then, future investigation with complementary DTI technique would be important.
In conclusion, our findings support the notion that motivational impairments in SCZ are associated with difficulty in translating reward information into motivated behavior. Our results indicate that cognitive and motivational impairment are related to distinct alterations suggesting at least a partial independence of these 2 domains of impairment.
Author Contributions
SG, AM and AA contributed to conception and design of the study, SG and AM also critically revised manuscript. MQ contributed to conception, analysis and interpretation of the data. MQ and AA drafted the manuscript. AP contributed to acquisition and analysis of the data; AS contributed to acquisition and interpretation of the data. EM contributed to interpretation of the data and critically revised the manuscript. AV, GMG and AN contributed to acquisition and interpretation of the data. All Authors contributed to critically revise the content, and approved the final manuscript.
Declaration of Conflicting Interests
The author(s) declared the following conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Galderisi received honoraria, advisory board, or consulting fees from the following companies: Angelini-Acraf, GedeonRichter, Hoffman-La Roche, Janssen Pharmaceuticals, Lundbeck, Otsuka, and Pierre Fabre. Dr Mucci received honoraria, advisory board, or consulting fees from the following companies: Janssen Pharmaceuticals, Otsuka, Pfizer, and Pierre Fabre. All other authors declare no conflicts of interest.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded in part by Compagnia di San Paolo, Turin, Italy, within the project 'Reward system and primary negative symptoms in schizophrenia' (Grant No.: 2008.24011 ).
